These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23159467)

  • 1. Efficacy of cocktail phage therapy in treating Vibrio cholerae infection in rabbit model.
    Jaiswal A; Koley H; Ghosh A; Palit A; Sarkar B
    Microbes Infect; 2013 Feb; 15(2):152-6. PubMed ID: 23159467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of different oral approaches to treat Vibrio cholerae infection in adult mice.
    Jaiswal A; Koley H; Mitra S; Saha DR; Sarkar B
    Int J Med Microbiol; 2014 May; 304(3-4):422-30. PubMed ID: 24656386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenic potential of vibriophages against an experimental infection with Vibrio cholerae O1 in the RITARD model.
    Bhowmick TS; Koley H; Das M; Saha DR; Sarkar BL
    Int J Antimicrob Agents; 2009 Jun; 33(6):569-73. PubMed ID: 19157799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Tail Fiber Protein and a Receptor-Binding Protein Mediate ICP2 Bacteriophage Interactions with Vibrio cholerae OmpU.
    Lim ANW; Yen M; Seed KD; Lazinski DW; Camilli A
    J Bacteriol; 2021 Jun; 203(13):e0014121. PubMed ID: 33875544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cocktail of three virulent bacteriophages prevents Vibrio cholerae infection in animal models.
    Yen M; Cairns LS; Camilli A
    Nat Commun; 2017 Feb; 8():14187. PubMed ID: 28146150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological activity & interaction of Vibrio cholerae bacteriophages in rabbit ileal loop.
    Sarkar BL; Chakrabarti AK; Koley H; Chakrabarti MK; De SP
    Indian J Med Res; 1996 Jul; 104():139-41. PubMed ID: 8783517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of lysogenic phage in the outbreak strains of Vibrio cholerae O139.
    Mitra SN; Kar S; Ghosh RK; Pajni S; Ghosh A
    J Med Microbiol; 1995 Jun; 42(6):399-403. PubMed ID: 7791203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vibrio cholerae infection, novel drug targets and phage therapy.
    Fazil MH; Singh DV
    Future Microbiol; 2011 Oct; 6(10):1199-208. PubMed ID: 22004038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers.
    García L; Jidy MD; García H; Rodríguez BL; Fernández R; Año G; Cedré B; Valmaseda T; Suzarte E; Ramírez M; Pino Y; Campos J; Menéndez J; Valera R; González D; González I; Pérez O; Serrano T; Lastre M; Miralles F; Del Campo J; Maestre JL; Pérez JL; Talavera A; Pérez A; Marrero K; Ledón T; Fando R
    Infect Immun; 2005 May; 73(5):3018-24. PubMed ID: 15845509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reviving Phage Therapy for the Treatment of Cholera.
    Bhandare S; Colom J; Baig A; Ritchie JM; Bukhari H; Shah MA; Sarkar BL; Su J; Wren B; Barrow P; Atterbury RJ
    J Infect Dis; 2019 Feb; 219(5):786-794. PubMed ID: 30395214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteriological profile of cholera in Tamil Nadu (1980-2001).
    Sundaram SP; Revathi J; Sarkar BL; Bhattacharya SK
    Indian J Med Res; 2002 Dec; 116():258-63. PubMed ID: 12807153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological characterization of v. Cholerae-specific bacteriophages isolated from water sources in Georgia.
    Elbakidze T; Kokashvili T; Janelidze N; Porchkhidze K; Koberidze T; Tediashvili M
    Georgian Med News; 2015 Mar; (240):65-72. PubMed ID: 25879562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of a dominant lineage of Vibrio cholerae-specific lytic bacteriophages shed by cholera patients over a 10-year period in Dhaka, Bangladesh.
    Seed KD; Bodi KL; Kropinski AM; Ackermann HW; Calderwood SB; Qadri F; Camilli A
    mBio; 2011; 2(1):e00334-10. PubMed ID: 21304168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmission of Vibrio cholerae is antagonized by lytic phage and entry into the aquatic environment.
    Nelson EJ; Chowdhury A; Flynn J; Schild S; Bourassa L; Shao Y; LaRocque RC; Calderwood SB; Qadri F; Camilli A
    PLoS Pathog; 2008 Oct; 4(10):e1000187. PubMed ID: 18949027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolutionary consequences of intra-patient phage predation on microbial populations.
    Seed KD; Yen M; Shapiro BJ; Hilaire IJ; Charles RC; Teng JE; Ivers LC; Boncy J; Harris JB; Camilli A
    Elife; 2014 Aug; 3():e03497. PubMed ID: 25161196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling the role of bacteriophage in the control of cholera outbreaks.
    Jensen MA; Faruque SM; Mekalanos JJ; Levin BR
    Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4652-7. PubMed ID: 16537404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phage in the time of cholera.
    Weitz JS; Hartman H
    Lancet Infect Dis; 2006 May; 6(5):257-8. PubMed ID: 16631542
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of phage on the infectivity of Vibrio cholerae and emergence of genetic variants.
    Zahid MS; Udden SM; Faruque AS; Calderwood SB; Mekalanos JJ; Faruque SM
    Infect Immun; 2008 Nov; 76(11):5266-73. PubMed ID: 18794293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diminished diarrheal response to Vibrio cholerae strains carrying the replicative form of the CTX(Phi) genome instead of CTX(Phi) lysogens in adult rabbits.
    Faruque SM; Rahman MM; Hasan AK; Nair GB; Mekalanos JJ; Sack DA
    Infect Immun; 2001 Oct; 69(10):6084-90. PubMed ID: 11553546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and protective efficacy of Vibrio cholerae outer membrane vesicles in rabbit model.
    Roy N; Barman S; Ghosh A; Pal A; Chakraborty K; Das SS; Saha DR; Yamasaki S; Koley H
    FEMS Immunol Med Microbiol; 2010 Oct; 60(1):18-27. PubMed ID: 20528929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.